When does MEVIS MEDICAL SOLUTIONS AG (M3V.DE) report earnings?
MEVIS MEDICAL SOLUTIONS AG (M3V.DE) will report earnings on 2026-05-21.
MEVIS MEDICAL SOLUTIONS AG (M3V.DE) Forecast, Price Target & Analyst Ratings
FRA:M3V • DE000A0LBFE4
Current stock price
22.6 EUR
+0.2 (+0.89%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MEVIS MEDICAL SOLUTIONS AG (M3V.DE).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of €22.60 to mean target of N/A, Based on 7 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
45.71%
M3V.DE was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about M3V.DE.
In the previous month the buy percentage consensus was at a similar level.
M3V.DE was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 21, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 18.762M 15.71% | 17.342M -7.57% | 16.972M -2.13% | |
| EBITDA YoY % growth | 6.563M 44.42% | 5.001M -23.80% | 4.135M -17.32% | |
| EBIT YoY % growth | 6.47M 46.41% | 4.905M -24.19% | 4.002M -18.41% | |
| Operating Margin | 34.48% | 28.28% | 23.58% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A